Biomechanical and Viscoelastic Properties of Thoracolumbar Fascia in Pregnancy Pelvic Girdle Pain

Investigation of Biomechanical and Viscoelastic Properties of Thoracolumbar Fascia in Pregnant Women With Pelvic Girdle Pain

It has not been objectively clarified how the thoracolumbar fascia (TLF) changes the biomechanical adaptations that occur in the lumbopelvic region during pregnancy and whether it is associated with pelvic girdle pain (PGP). Therefore, the aim of this study is to determine the biomechanical and viscoelastic properties of TLF, which adapts to the changes in the lumbopelvic region in pregnant women with pelvic girdle pain, and to investigate its relationship with PGP.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • İstanbul, Turkey
        • Istanbul Medeniyet University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Pregnant women with and without PGP and non-pregnant women

Description

Inclusion Criteria:

  • First-time pregnancy
  • Pregnant women diagnosed with pelvic girdle pain in 1st and 2nd trimesters
  • Pregnant women who do not have pelvic girdle pain in 1st and 2nd trimesters
  • Women not being pregnant
  • Pre-pregnancy Body-Mass-Index (BMI) < 30 kg/m2

Exclusion Criteria:

  • Presence of connective tissue disease
  • Deterioration of skin integrity in measurement areas
  • Presence of orthopedic, neurological, rheumatic problems that may cause musculoskeletal disorders and deviations from normal biomechanical alignment
  • History of spine, pelvis, or lower extremity surgery or fracture in the past 6 months
  • Definition of chronic low back-pelvic region pain (lasting for more than 3 months and pain severity >4 according to VAS) before pregnancy
  • Identification of metabolic disorders such as Type I, II diabetes, gestational diabetes mellitus (GDM), preeclampsia before and/or during pregnancy)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1: Pregnant women with pelvic girdle pain
This group will consist of pregnant women diagnosed with pelvic girdle pain.
The severity of pelvic girdle pain will be evaluated with the Visual Analog Scale (VAS).
Pelvic girdle pain diagnostic tests will be applied.
The biomechanical and viscoelastic properties of the thoracolumbar fascia will be measured in the prone position and measurements will be taken from three different points
Pelvic Girdle Questionnaire will be filled
Group 2: Pregnant women without pelvic girdle pain
This group will consist of pregnant women who do not have pelvic girdle pain.
The severity of pelvic girdle pain will be evaluated with the Visual Analog Scale (VAS).
Pelvic girdle pain diagnostic tests will be applied.
The biomechanical and viscoelastic properties of the thoracolumbar fascia will be measured in the prone position and measurements will be taken from three different points
Pelvic Girdle Questionnaire will be filled
Group 3: Non-pregnant women
This group will consist of non-pregnant women.
The biomechanical and viscoelastic properties of the thoracolumbar fascia will be measured in the prone position and measurements will be taken from three different points

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of biomechanical properties of thoracolumbar fascia
Time Frame: Measurement the change from baseline stiffness values of Thoracolumbar fascia at 12. week and at 22. week
Measuring of the stiffness (N/m) of the thoracolumbar fascia (with MyotonPro, Myoton AS, Tallin, Estonia) in the prone position.
Measurement the change from baseline stiffness values of Thoracolumbar fascia at 12. week and at 22. week
Evaluation of biomechanical properties of thoracolumbar fascia
Time Frame: Measurement the change from baseline decrement values of Thoracolumbar fascia at 12. week and at 22. week
Measuring of the decrement of the thoracolumbar fascia (with MyotonPro, Myoton AS, Tallin, Estonia) in the prone position.
Measurement the change from baseline decrement values of Thoracolumbar fascia at 12. week and at 22. week
Evaluation of biomechanical properties of thoracolumbar fascia
Time Frame: Measurement the change from baseline tone values of Thoracolumbar fascia at 12. week and at 22. week
Measuring of the tone (Hz) of the thoracolumbar fascia (with MyotonPro, Myoton AS, Tallin, Estonia) in the prone position.
Measurement the change from baseline tone values of Thoracolumbar fascia at 12. week and at 22. week
Evaluation of viscoelastic properties of thoracolumbar fascia
Time Frame: Measurement the change from baseline creep values of Thoracolumbar fascia at 12. week and at 22. week
Measuring of the creep of the thoracolumbar fascia (with MyotonPro, Myoton AS, Tallin, Estonia) in the prone position.
Measurement the change from baseline creep values of Thoracolumbar fascia at 12. week and at 22. week
Evaluation of viscoelastic properties of thoracolumbar fascia
Time Frame: Measurement the change from baseline relaxation time values of Thoracolumbar fascia at 12. week and at 22. week
Measuring of thethe relaxation time (ms) of the thoracolumbar fascia (with MyotonPro, Myoton AS, Tallin, Estonia) in the prone position.
Measurement the change from baseline relaxation time values of Thoracolumbar fascia at 12. week and at 22. week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Application of PGP diagnostic tests
Time Frame: Baseline
Pelvic Girdle Pain diagnostic tests will be applied.
Baseline
Pelvic Girdle Questionnaire
Time Frame: Baseline
Activity limitation will be evaluated Pelvic Girdle Questionnaire
Baseline
Determining of painful areas
Time Frame: Baseline
Marking of body chart
Baseline
Evaluation of pain
Time Frame: Baseline
Pain will be evaluated with Visual analog scale (VAS). The VAS is scaled between 0-10 points (0: no pain, 10: most severe pain).
Baseline
Evaluation of Body Weight
Time Frame: Measurement the change from baseline body weight (kg) at 12. and 22. weeks.
Measuring of the Body Weight
Measurement the change from baseline body weight (kg) at 12. and 22. weeks.
Evaluation of Body Mass Index (BMI)
Time Frame: Measurement the change from baseline BMI values at 12.and 22. weeks
BMI (kg/m2) will be calculated as person's weight in kilograms divided by the square of height in meters.
Measurement the change from baseline BMI values at 12.and 22. weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2022

Primary Completion (Anticipated)

June 15, 2023

Study Completion (Anticipated)

December 15, 2023

Study Registration Dates

First Submitted

April 15, 2022

First Submitted That Met QC Criteria

May 31, 2022

First Posted (Actual)

June 3, 2022

Study Record Updates

Last Update Posted (Actual)

June 3, 2022

Last Update Submitted That Met QC Criteria

May 31, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnant Women

Clinical Trials on Evaluation of pain

Subscribe